Batavia Bioservices aims to significantly contribute to ease human suffering from disease by improving the success rate in the translation of candidate medicines from discovery to the clinic.
In the rapidly growing market of biopharmaceuticals we offer our novel technologies and know how in order to help our customers to complete their preclinical phases in product development at higher speed, reduced cost, and with higher success rate.read more >>
Currently we are looking for (a):
- Technician Molecular Biology
- Account Manager
- Temporary Associate Scientist, Part-time, Woburn, MA
- Team Leader USP, Leiden, The Netherlands
Batavia Bioservices has won the High Growth Award
for the region Zuid-Holland and Zeeland!
This Award is an initiative from Port4Growth with as partners Rabobank and Grant Thornton. BBS demonstrated strong growth in revenues over the last three years.
read more >>
Batavia Bioservices nominated for the 2014 FD Gazelle Award!
This Award is an initiative from the "Financieel Dagblad" with as partners ABN-AMRO, Graydon, and Mazars Accounting firm.
Nominees are scored on their growth in total revenue over the last three business years and should at least demonstrate a 20% year on year growth.
read more >>
Launching the STEP™ CHO protein expression platform
We have launched the STEP™ CHO protein expression platform at the IBC Cell Line Development Congress in Berkley, CA with a presentation from Femke Hoeksma (Team Leader) at 9 September. The congress took place from 8 - 10 September 2014. read more about STEP >>
Batavia Bioservices offers a portfolio of services focused on the rapid and cost effective provision of high quality biopharmaceutical materials for research and pre-clinical studies. Services include:
Batavia Bioservices is strongly committed to the development of new technologies and innovations within the field of biopharmaceutical research and development. We focus on technology which ultimately leads to the development of better medicines at reduced cost and time.